Psychedelic Mushrooms Are Closer to Medicinal Use (It’s Not Just Your Imagination)

Researchers from Johns Hopkins University have recommended that psilocybin, the active compound in hallucinogenic mushrooms, be reclassified for medical use, potentially paving the way for the psychedelic drug to one day treat depression and anxiety and help people stop smoking. The suggestion to reclassify psilocybin from a Schedule I drug, with no known medical benefit,…